These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 18757728)
41. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Sobel ML; Hocquet D; Cao L; Plesiat P; Poole K Antimicrob Agents Chemother; 2005 May; 49(5):1782-6. PubMed ID: 15855496 [TBL] [Abstract][Full Text] [Related]
42. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated. Evans K; Poole K FEMS Microbiol Lett; 1999 Apr; 173(1):35-9. PubMed ID: 10220878 [TBL] [Abstract][Full Text] [Related]
43. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922 [TBL] [Abstract][Full Text] [Related]
44. Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals. Castanheira M; Doyle TB; Smith CJ; Mendes RE; Sader HS J Antimicrob Chemother; 2019 Sep; 74(9):2588-2595. PubMed ID: 31225882 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035 [TBL] [Abstract][Full Text] [Related]
46. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [TBL] [Abstract][Full Text] [Related]
47. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related]
48. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM. Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596 [TBL] [Abstract][Full Text] [Related]
49. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG). Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815 [TBL] [Abstract][Full Text] [Related]
50. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. Sugimura M; Maseda H; Hanaki H; Nakae T Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884 [TBL] [Abstract][Full Text] [Related]
51. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. Tikhonova EB; Wang Q; Zgurskaya HI J Bacteriol; 2002 Dec; 184(23):6499-507. PubMed ID: 12426337 [TBL] [Abstract][Full Text] [Related]
52. Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Pumbwe L; Piddock LJ Antimicrob Agents Chemother; 2000 Oct; 44(10):2861-4. PubMed ID: 10991874 [TBL] [Abstract][Full Text] [Related]
53. The outer membrane component of the multidrug efflux pump from Pseudomonas aeruginosa may be a gated channel. Yoshihara E; Maseda H; Saito K Eur J Biochem; 2002 Oct; 269(19):4738-45. PubMed ID: 12354104 [TBL] [Abstract][Full Text] [Related]
54. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL mBio; 2017 Jul; 8(4):. PubMed ID: 28743808 [TBL] [Abstract][Full Text] [Related]
55. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333 [TBL] [Abstract][Full Text] [Related]
56. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203 [TBL] [Abstract][Full Text] [Related]
57. Organic solvent-tolerant mutants of Pseudomonas aeruginosa display multiple antibiotic resistance. Li XZ; Poole K Can J Microbiol; 1999 Jan; 45(1):18-22. PubMed ID: 10349716 [TBL] [Abstract][Full Text] [Related]
58. Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system. Fruci M; Poole K PLoS One; 2018; 13(10):e0205036. PubMed ID: 30289929 [TBL] [Abstract][Full Text] [Related]
59. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Schweizer HP Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802 [TBL] [Abstract][Full Text] [Related]
60. Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa. Jalal S; Wretlind G; Gotoh N; Wretlind B APMIS; 1999 Dec; 107(12):1109-16. PubMed ID: 10660141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]